Madrigal Pharmaceuticals Inc MDGL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
MADRIGAL PHARMACEUTICALS, INC. MDGL INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 8.1% Share Drop
MDGL INVESTIGATION NOTICE: Hagens Berman, National Securities Law Firm, Investigating Madrigal Pharmaceuticals (NASDAQ: MDGL) Following Whistleblower Allegations of Clinical Data Integrity Concerns
MDGL Investors Have Opportunity to Join Madrigal Pharmaceuticals, Inc. Fraud Investigation with SBS Law
Notice of Investigation of MDGL: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP
NASDAQ: MDGL INVESTIGATION ALERT: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP
Lost Money on Madrigal Pharmaceuticals, Inc. Stock? Glancy Prongay Wolke & Rotter LLP Investigates Possible Securities Fraud After 8.1% Share Price Drop
Did You Lose Money on Madrigal Pharmaceuticals, Inc. Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 8.1% Share Price Decline
Lost Money on Madrigal Pharmaceuticals, Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 8.1% Stock Decline
Trading Information
- Previous Close Price
- $432.60
- Day Range
- $431.55–440.21
- 52-Week Range
- $353.54–615.00
- Bid/Ask
- $400.00 / $429.00
- Shares Outstanding
- 23.23M
- Market Cap
- $10.06B
- Volume/Avg
- 296,888 / 351,741
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 7.00
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 0.06%
Company Profile
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 915
Valuation
Metric | MDGL |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 16.04 |
Price/Sales | 7.00 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | MDGL |
|---|---|
Quick Ratio | 2.62 |
Current Ratio | 3.05 |
Interest Coverage | −4.87 |
Quick Ratio
MDGL
Profitability
Metric | MDGL |
|---|---|
Return on Assets (Normalized) | −1.63% |
Return on Equity (Normalized) | −3.65% |
Return on Invested Capital (Normalized) | −2.39% |
Return on Assets
MDGL
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|klQ%<z | LOCK|$?WF | $139B | |||
| Moderna Inc MRNA | LOCK|dW&Ts$& | LOCK|Zc? | $101B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|#X#ZJ<% | LOCK|xVNp | $95B | |||
| argenx SE ADR ARGX | LOCK|gmVv>X$ | LOCK|L! | $61B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|Q&>Pj!C | LOCK|X^ | $49B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|yJXm<Nb | LOCK|$N@%@ | $31B | |||
| Incyte Corp INCY | LOCK|f<Q#<< | LOCK|Y$T | $25B | |||
| BioNTech SE ADR BNTX | LOCK|lJ!HfM | LOCK|hr> | $22B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|Cy>dp>! | LOCK|THn!Y | $20B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|WFV&>L | LOCK|w% | $16B |
United States